Terumo Cardiovascular Group, a global leader in cardiovascular surgery technologies, and Talis Clinical, a leading provider of healthcare software solutions, announced a global strategic partnership.
Terumo has made a minority interest investment in the Ohio software company and will provide a distribution channel for Talis Clinical’s software into cardiovascular operating rooms (CVOR) and intensive care units (CVICU). The partnership allows Talis Clinical to further expand its products into the cardiac care space.
Robert DeRyke, Terumo Cardiovascular Group’s President and CEO, has joined the Talis Clinical Board of Directors.
Terumo expects to begin selling Talis’ Advanced Clinical Guidance Systems for the CVOR and CVICU in Spring 2019 with a unique application for ECMO management coming later in 2019.
Talis Clinical’s Advanced Clinical Guidance System delivers intelligent data through user-created, context-filled clinical and operational guidances that enhance the efficiency of the entire cardiac care team.
“The state-of-the-art software complements Terumo’s trusted line of products for perfusion and the cardiovascular operating room,” said DeRyke. “I look forward to working with Talis Clinical as both a business partner and board member, to connect clinicians with smart, real-time data that enables the best possible patient care.”
“Talis and Terumo both share a similar commitment to safe patient outcomes through confident, engaging clinician workflows,” said Gary Colister, President and Founder of Talis Clinical. “Talis’ Advanced Clinical Guidance applications improve the collaboration and vigilance of caregivers from the operating room through cardiovascular intensive care units and beyond. My team is thrilled to partner with Terumo to bring our applications to patients throughout the world.”
Source: Company Press Release